Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Network
-
Novel Immunotherapy Targeting IGF1R/IR in TNBC
V FOUNDATION FOR CANCER RESEARCH
3/15/22 → 3/15/23
Project: Research project
-
A Global Phase 2 Study to Evaluate the Efficacy andSafety of ARX788 for Selected HER2-mutated orHER2-amplified/over-expressed Solid Tumors
3/4/22 → 3/31/27
Project: Research project
-
Natural Killer Cell Mediated Immunotherapy for Hormone Receptor Positive Metastatic Breast Cancer
Sachdev, D., Beckwith, H. C., Felices, M. & Hackel, B. J.
9/1/20 → 8/31/22
Project: Research project
-
A multi-centre, double-blind, placebo-controlled, randomised phase II trial to compare efficacy of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in post-menopausal women with HR+ / HER2- metastatic breast can
Boehringer-Ingelheim Pharmaceuticals
8/30/18 → 8/30/23
Project: Research project
-
-
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients
I-SPY 2 Trial Consortium, Jan 2022, In: The Lancet Oncology. 23, 1, p. 149-160 12 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer
Jenkins, J. A., Marmor, S., Hui, J., Beckwith, H., Blaes, A. H., Potter, D. A. & Tuttle, T. M., Jan 2022, In: Breast Cancer Research and Treatment. 191, 2, p. 401-407 7 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
Pusztai, L., Yau, C., Wolf, D. M., Han, H. S., Du, L., Wallace, A. M., String-Reasor, E., Boughey, J. C., Chien, A. J., Elias, A. D., Beckwith, H., Nanda, R., Albain, K. S., Clark, A. S., Kemmer, K., Kalinsky, K., Isaacs, C., Thomas, A., Shatsky, R., Helsten, T. L. & 25 others, , Jul 12 2021, In: Cancer Cell. 39, 7, p. 989-998.e5Research output: Contribution to journal › Article › peer-review
16 Scopus citations -
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer
Yee, D., Isaacs, C., Wolf, D. M., Yau, C., Haluska, P., Giridhar, K. V., Forero-torres, A., Jo Chien, A., Wallace, A. M., Pusztai, L., Albain, K. S., Ellis, E. D., Beckwith, H., Haley, B. B., Elias, A. D., Boughey, J. C., Kemmer, K., Yung, R. L., Pohlmann, P. R., Tripathy, D. & 35 others, , Dec 1 2021, In: npj Breast Cancer. 7, 1Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis
Wang, H., Zhang, S., Yee, D., Basu, S., Beckwith, H. C., Potter, D. A. & Blaes, A. H., May 2021, In: Breast Cancer. 28, 3, p. 618-629 12 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations
Datasets
-
COVID-19 Concerns among Physicians who treat cancer survey in the United States, Cross-sectional study March/April 2020
Vogel, R., Bollinger, L. T., Lou, E., Teoh, D. G., Jewett, P. I., Beckwith, H. C., Parsons, H. M., Yuan, J., Blaes, A. H. & Hui, J., Data Repository for the University of Minnesota, 2020
DOI: 10.13020/bmsy-hb61, http://hdl.handle.net/11299/216451
Dataset